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a-Amylase is an endoamylase and belongs to glyco-
side hydrolase family 13 (GH 13) according to the
classification of carbohydrate-active enzymes [1]. It
initiates starch hydrolysis into smaller oligomers. Inhi-
bitors of this enzyme are of pharmacological impor-
tance as a-amylase is considered as attractive target
for treating elevated post-prandial blood glucose levels
resulting in obesity and type II diabetes. Besides the
application as a drug, it is highly interesting to classify
nutritional components, such as food additives or second-
ary plant metabolites with respect to their modulation of
a-amylase.
We present a model that predicts the affinity of small
organic molecules to a- amylase. On the basis of avail-
able crystal structures (Figure 1) [2], we developed a
virtual screening workflow for the identification of novel
non- peptidic, non-carbohydrate a-amylase inhibitors. In
addition to virtual screening using structure-based 3D
pharmacophore models [3], molecular docking and clus-
tering for diversity selection have been applied as post-
screening filters. Fourteen virtual hits were purchased
and tested in vitro using a kinetic assay with p-Nitrophe-
nyl-a-d-maltopentaoside (PNPG5) as a chromogenic
substrate. Three of those fourteen compounds showed
concentration-dependent inhibition with promising IC50
values (hit rate: 21%).
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Figure 1 Subsites of a-amylase with Acarviostatin II03 inhibitor, (ki ~ 14 nM) (PDB entry: 3OLE) and starch. Site of cleavage is between subsites -1
and +1.
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